Edition:
United States

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

23.78USD
20 Feb 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$23.78
Open
$24.00
Day's High
$24.00
Day's Low
$23.40
Volume
8,593
Avg. Vol
7,912
52-wk High
$34.10
52-wk Low
$16.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.434
Jun '18 0.00 -0.645
Mar '18 0.00 -0.531
FY 2017 Dec '17 0.00 -0.396
Sep '17 0.00 -0.539
Jun '17 0.00 -0.917
Mar '17 0.00 -0.451
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 4 0.00 0.00 0.00 --
Quarter Ending Jun-19 4 0.12 0.50 0.00 --
Year Ending Dec-19 6 6.66 14.07 2.19 23.19
Earnings (per share)
Quarter Ending Mar-19 3 -0.60 -0.58 -0.62 --
Quarter Ending Jun-19 3 -0.76 -0.63 -0.92 --
Year Ending Dec-19 4 -2.20 -1.81 -2.51 -2.37
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 87.17 36.18
P/E High - Last 5 Yrs. -- 132.56 51.29
P/E Low - Last 5 Yrs. -- 50.34 25.93
Beta 2.60 1.07 0.96
Price to Sales (TTM) -- 51.74 10.03
Price to Book (MRQ) 4.53 12.17 4.56
Price to Tangible Book (MRQ) 5.31 17.52 5.67
Price to Cash Flow (TTM) -- 62.09 26.61
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.58
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.75 -7.60
Payout Ratio(TTM) -- 9.64 58.65

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 39.47 13.75
Sales (TTM) vs TTM 1 Yr. Ago -100.00 26.96 5.72
Sales - 5 Yr. Growth Rate -- 23.40 8.78
EPS (MRQ) vs Qtr. 1 Yr. Ago 19.50 18.88 5.30
EPS (TTM) vs TTM 1 Yr. Ago 50.15 -- --
EPS - 5 Yr. Growth Rate -- 19.09 8.39
Capital Spending - 5 Yr. Growth Rate -35.21 11.28 9.39

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.72 2.54
Current Ratio (MRQ) 21.96 3.54 3.50
LT Debt to Equity (MRQ) 0.00 6.05 13.03
Total Debt to Equity (MRQ) 0.00 20.09 16.56
Interest Coverage (TTM) -43.69 19.26 40.96

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.70 51.09
Gross Margin - 5 Yr. Avg. -- 63.50 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -733.32 5.89 17.43
Operating Margin (TTM) -- -269.37 -6.00
Operating Margin - 5 Yr. Avg. -794.29 -10.46 12.35
Pre-Tax Margin (TTM) -- -260.18 -5.09
Pre-Tax Margin - 5 Yr. Avg. -823.78 -14.46 12.49
Net Profit Margin (TTM) -- -267.27 -8.64
Net Profit Margin - 5 Yr. Avg. -823.78 -20.03 8.77
Effective Tax Rate (TTM) -- 21.74 22.21
Effective Tax Rate - 5 Yr. Avg. -- 18.49 23.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,673,613 783,604,815
Net Income/Employee (TTM) -2,833,110 1,806,560 90,784,808
Receivable Turnover (TTM) -- 2.32 4.84
Inventory Turnover (TTM) -- 1.93 3.72
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.04 8.26 10.16
Return on Assets - 5 Yr. Avg. -94.84 6.62 11.04
Return on Investment (TTM) -50.09 10.35 12.67
Return on Investment - 5 Yr. Avg. -117.79 8.69 14.21
Return on Equity (TTM) -50.09 10.64 13.70
Return on Equity - 5 Yr. Avg. -164.52 9.20 15.31
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 83.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Acer Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.43 -8.53 29 83
13 Week 10.88 5.38 65 21
26 Week -22.19 -19.86 44 9
52 Week 37.88 35.52 84 8
YTD 19.04 7.35 61 8
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 59.34%
# of Holders: 44
Total Shares Held: 5,965,022
3 Mo. Net Change: 42,547
# New Positions: 8
# Closed Positions: 9
# Increased Positions: 21
# Reduced Positions: 16
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.